Trending...
- Chicago: Mayor Brandon Johnson, DOH Break Ground on LeClaire Courts North, Bringing 124 Affordable Homes to Garfield Ridge
- Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
From equations and experiments in the laboratory to exclusive skincare for skin longevity
WILMINGTON, Del. - illiNews -- Biophysical Therapeutics, a Delaware company, announces the launch of its consumer longevity brand called IF1.
It is currently accepting pre-orders for its first product, an anti-aging skin moisturizer available at www.IF1.skin. Only 500 units are available in the initial production run, retailing at $120 apiece.
This moisturizer is distinctive in incorporating leading-edge longevity science, and is further distinct, since the profit from its sales will feed back to fund the company's drug programs, which include drugs against cancer, age-related diseases (such as Alzheimer's disease), and aging itself.
The company was founded in 2022 by Dr. Michael Forrest, a Cambridge University biochemistry graduate with a Ph.D. in computer science, and is advised by Professor George Church of Harvard Medical School. Its specialty is computational biology and especially biophysical modeling, which is mathematical modeling of the physics and chemistry of a biological system, and the company is named after this approach. Unusually for a computational biology company, it has actually delivered new experimentally-validated drugs working as predicted in vivo, protected by granted patents.
More on illi News
The science behind the company's new anti-aging skin moisturizer is its conclusion regarding why different mammal species can have such different lifespans, for example, a mouse maximally lives 4 years whereas a bowhead whale can live centuries longer. This conclusion is complex but it distills to simplicity - species with more IF1 protein live longer. Indeed, the company has shown that increasing IF1 protein in mice reduces aging as measured by an aging biomarker.
People already buy anti-aging skincare. Indeed, it is already a $70B market and growing. This bodes well for this new brand that leverages differentiated anti-aging science from leading anti-aging scientists, which will in turn fund them to advance science and medicine. Economists calculate that the economic benefit of slower aging, to the USA alone, is $38T per year of increased life expectancy.
Dr. Forrest says: "Our IF1 brand brings leading-edge anti-aging science to skincare. This is just part of our mission to save, improve, and extend lives at mass scale."
More on illi News
The IF1 anti-aging skin moisturizer is available for pre-order now exclusively at www.IF1.skin.
About Biophysical Therapeutics
Biophysical Therapeutics is a Delaware-based biotechnology company that uses computational biology, especially biophysical modeling, to discover new fundamental biology and design new drugs. Its primary targets are cancer, the diseases of aging (e.g., Alzheimer's disease), and aging itself. The company has a pipeline of experimentally-validated new drugs and a portfolio of granted patents. It owns a longevity skincare brand called IF1, which is available at www.IF1.skin.
It is currently accepting pre-orders for its first product, an anti-aging skin moisturizer available at www.IF1.skin. Only 500 units are available in the initial production run, retailing at $120 apiece.
This moisturizer is distinctive in incorporating leading-edge longevity science, and is further distinct, since the profit from its sales will feed back to fund the company's drug programs, which include drugs against cancer, age-related diseases (such as Alzheimer's disease), and aging itself.
The company was founded in 2022 by Dr. Michael Forrest, a Cambridge University biochemistry graduate with a Ph.D. in computer science, and is advised by Professor George Church of Harvard Medical School. Its specialty is computational biology and especially biophysical modeling, which is mathematical modeling of the physics and chemistry of a biological system, and the company is named after this approach. Unusually for a computational biology company, it has actually delivered new experimentally-validated drugs working as predicted in vivo, protected by granted patents.
More on illi News
- Expedition Money Launches "Woodland Cents" a 53-Book Children's Series That Teaches Kids About Money
- Heritage at South Brunswick Announces Special Townhome Mortgage Rate Buydown
- Heritage at Hopewell Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Townhomes
- Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton
- Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
The science behind the company's new anti-aging skin moisturizer is its conclusion regarding why different mammal species can have such different lifespans, for example, a mouse maximally lives 4 years whereas a bowhead whale can live centuries longer. This conclusion is complex but it distills to simplicity - species with more IF1 protein live longer. Indeed, the company has shown that increasing IF1 protein in mice reduces aging as measured by an aging biomarker.
People already buy anti-aging skincare. Indeed, it is already a $70B market and growing. This bodes well for this new brand that leverages differentiated anti-aging science from leading anti-aging scientists, which will in turn fund them to advance science and medicine. Economists calculate that the economic benefit of slower aging, to the USA alone, is $38T per year of increased life expectancy.
Dr. Forrest says: "Our IF1 brand brings leading-edge anti-aging science to skincare. This is just part of our mission to save, improve, and extend lives at mass scale."
More on illi News
- AI Agents Are Getting Their Own Computers. HRTech Leading in Vertical Harness Development
- UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
- MAZ6R CLAN (MAZ6R), Launches A New Visual Concept in Website Design!
- Isringhausen Imports to Host Exclusive Launch Party for the All-New Porsche Cayenne Electric
- Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
The IF1 anti-aging skin moisturizer is available for pre-order now exclusively at www.IF1.skin.
About Biophysical Therapeutics
Biophysical Therapeutics is a Delaware-based biotechnology company that uses computational biology, especially biophysical modeling, to discover new fundamental biology and design new drugs. Its primary targets are cancer, the diseases of aging (e.g., Alzheimer's disease), and aging itself. The company has a pipeline of experimentally-validated new drugs and a portfolio of granted patents. It owns a longevity skincare brand called IF1, which is available at www.IF1.skin.
Source: Biophysical Therapeutics
Filed Under: Health
0 Comments
Latest on illi News
- Chicago: Mayor Brandon Johnson, DPD Congratulate Griffin Museum of Science and Industry on South Portico Groundbreaking
- Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources
- Mayor Brandon Johnson Releases 2027 Budget Engagement Report: Chicagoans Call For Taxes on Corporations, Protection of City Services, and Investment
- Hilton Waikiki Beach Resort & Spa Introduces Level 37 Sky Lounge by Casamigos
- Self-Published Dad's Santa Book Finally Found After 3 Years on Amazon
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
- Patented Plumb Rite Adjustable Waste & Overflow Assembly Introduces Flexible Approach to Bathtub Plumbing Installation
- Best Hardwood Floors for Pets: Top Choices Explained
- Citizens for West Virginia Election Integrity Urges "FOR" on Amendment 1
- Vegan Kingz Expands Direct-Import Wholesale Lineup to Help Commercial Kitchens Cut Ingredient Costs
- New STLE Special Report Examines Next-Generation Gear Lubricants for Electric Vehicles
- Everything Policy Unveils Their Classroom Resources Behind Every Policy Topic
- Acuvance Survey Finds ERP Integration Remains a Key Challenge as Healthcare Organizations Prepare for AI
- Constantine "Costa" Kapothanasis II Acquires The Lubri-Loy Company, Carrying a 77-Year-Old American Lubricant Brand Into Its Next Era
- LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
- Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments
- Industrial & systems engineering educator and professional to lead global strategic partnerships for professional society
- Convergence of AI, Wearable Technology, Remote Patient Monitoring and Real-World Healthcare: PomDoctor Ltd. (N A S D A Q: POM)
- Service Guys Urges Ontario Homeowners to Book Chimney Cleaning and WETT Inspections Before the 2026 Heating Season
- WOWX Completes Its Transition from CEX to Decentralized Derivatives Infrastructure